Genetics and Rare Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Department of Pediatrics, Sapienza University, Rome, Italy.
Clin Genet. 2023 Feb;103(2):156-166. doi: 10.1111/cge.14247. Epub 2022 Nov 24.
CNOT2 haploinsufficiency underlies a rare neurodevelopmental disorder named Intellectual Developmental disorder with NAsal speech, Dysmorphic Facies, and variable Skeletal anomalies (IDNADFS, OMIM 618608). The condition clinically overlaps with chromosome 12q15 deletion syndrome, suggesting a major contribution of CNOT2 haploinsufficiency to the latter. CNOT2 is a member of the CCR4-NOT complex, which is a master regulator of multiple cellular processes, including gene expression, RNA deadenylation, and protein ubiquitination. To date, less than 20 pathogenic 12q15 microdeletions encompassing CNOT2, together with a single truncating variant of the gene, and two large intragenic deletions have been reported. Due to the small number of affected subjects described so far, the clinical profile of IDNADFS has not been fully delineated. Here we report five unrelated individuals, three of which carrying de novo intragenic CNOT2 variants, one presenting with a multiexon intragenic deletion, and an additional case of 12q15 microdeletion syndrome. Finally, we assess the features of IDNADFS by reviewing published and present affected individuals and reevaluate the clinical phenotype of this neurodevelopmental disorder.
CNOT2 杂合性缺失是一种罕见的神经发育障碍,命名为伴有非鼻语音、畸形面容和可变骨骼异常的智力发育障碍(IDNADFS,OMIM 618608)。该病症与 12 号染色体 q15 缺失综合征在临床上重叠,表明 CNOT2 杂合性缺失对后者有重大影响。CNOT2 是 CCR4-NOT 复合物的成员,该复合物是多种细胞过程的主要调节剂,包括基因表达、RNA 去腺苷酸化和蛋白质泛素化。迄今为止,已报道了不到 20 个致病性 12q15 微缺失,包括 CNOT2 基因,以及一个截断变异体和两个大的基因内缺失。由于迄今为止描述的受影响个体数量较少,IDNADFS 的临床特征尚未完全描绘。在这里,我们报告了五个无关个体,其中三个携带新生基因内 CNOT2 变异体,一个表现为多外显子基因内缺失,还有一个额外的 12q15 微缺失综合征病例。最后,我们通过回顾已发表和目前受影响的个体来评估 IDNADFS 的特征,并重新评估这种神经发育障碍的临床表型。